Non-Lethal Bone Marrow Necrosis under First-Line Arsenic Trioxide Therapy in Acute Promyelocytic Leukaemia

Publisher： Karger

E-ISSN： 1421-9662|123|3|146-147

ISSN： 0001-5792

Source： Acta Haematologica, Vol.123, Iss.3, 2010-02, pp. : 146-147

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Tamibarotene in patients with acute promyelocytic leukaemia relapsing after treatment with all‐trans retinoic acid and arsenic trioxide

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 171, Iss. 4, 2015-11 ,pp. : 471-477

John Wiley & Sons Inc

Access to resources Recommend Favorite

Arsenic Trioxide in a Hemodialytic Patient with Acute Promyelocytic Leukemia

By  

Acta Haematologica, Vol. 122, Iss. 1, 2009-10 ,pp. : 52-53

Karger

Access to resources Recommend Favorite

High Frequency of Varicella Zoster Virus Reactivation Associated with the Use of Arsenic Trioxide in Patients with Acute Promyelocytic Leukemia

By  

Acta Haematologica, Vol. 131, Iss. 2, 2013-09 ,pp. : 76-77

Karger

Access to resources Recommend Favorite

Insights into the All-trans-Retinoic Acid and Arsenic Trioxide Combination Treatment for Acute Promyelocytic Leukemia: A Meta-Analysis

By  

Acta Haematologica, Vol. 134, Iss. 2, 2015-04 ,pp. : 101-108

Karger

Access to resources Recommend Favorite

Arsenic Trioxide Inhibits the Hedgehog Pathway Which Is Aberrantly Activated in Acute Promyelocytic Leukemia

By  

Acta Haematologica, Vol. 130, Iss. 4, 2013-07 ,pp. : 260-267

Karger

Access to resources Recommend Favorite